以肠系膜上动脉为导向的右半结肠全结肠系膜切除术治疗右半结肠癌的应用价值

Application value of superior mesenteric artery-oriented complete mesocolic excision in the treatment of right colon cancer

  • 摘要: 目的:探讨以肠系膜上动脉(SMA)为导向的右半结肠全结肠系膜切除术(CME)治疗右半结肠癌的应用价值。
    方法:采用回顾性队列研究方法。收集2013年1月至2018年6月南京医科大学第一附属医院收治的955例右半结肠癌患者的临床病理资料;男514例,女441例;中位年龄为65岁,年龄范围为18~96岁。955例患者中,377例行以SMA为导向的右半结肠CME,淋巴结清扫内侧界为SMA左缘,设为动脉导向组;578例行以肠系膜上静脉(SMV)为导向的右半结肠CME,淋巴结清扫内侧界为SMV左缘,设为静脉对照组。观察指标:(1)术中及术后情况。(2)术后并发症发生情况。(3)术后病理学检查情况。(4)随访和生存情况。采用电话和门诊方式对患者进行随访,术后2年内每3~6个月随访1次,2年后每1年随访1次。随访内容为患者体格检查,肿瘤标志物检查,包括癌胚抗原、CA199,胸腹CT检查和肠镜检查。随访终点为发现肿瘤复发转移或患者死亡。随访时间截至2019年1月。偏态分布的计量资料以M(P25,P75)表示,组间比较采用Mann-Whitney U检验。计数资料以绝对数或百分比表示,组间比较采用x2检验。等级资料采用秩和检验。采用Kaplan-Meier法计算生存时间和生存率,并绘制生存曲线。采用Log-rank检验进行生存情况分析。失访患者作为删失值纳入生存分析。
    结果:(1)术中及术后情况:377例动脉导向组患者手术时间,术中出血量,术后住院时间分别为100 min(90 min,110 min),50.0 mL(50.0 mL,70.0 mL),8 d(8 d, 10 d);578例静脉对照组患者上述指标分别为110 min(90 min,135 min),50.0 mL(50.0 mL,122.5 mL)、 10 d(8 d,12 d),两组患者上述指标比较,差异均有统计学意义(Z=-5.400,-5.799,-7.461,P<0.05)。排除47例术后并发症患者,365例动脉导向组患者术后首次肛门排便时间, 术后每天最大排便次数,术后每天中位排便次数分别为5 d(3 d,5 d),2.0次(1.0次,2.5次),1.0次 (1.0次,1.0次);543例静脉对照组患者上述指标分别为4 d(3 d,5 d),2.0次(1.0次,3.0次),1.0次(1.0次, 1.0次),两组患者上述指标比较,差异均无统计学意义(Z=-1.622,-1.541,-1.024,P>0.05)。(2)术后并发症发生情况:377例动脉导向组患者中,术后并发症、切口液化和(或)感染、吻合口漏、胃排空障碍、腹腔出血、完全和(或)不全性肠梗阻、吻合口出血、腹腔感染、切口裂开、术后死亡分别为55、10、3、3、2、2、1、1、1、1例;578例静脉对照组患者上述指标分别为83、30、13、4、3、8、3、6、2、3例,两组患者上述指标比较,差异均无统计学意义(x2=0.045,3.662,2.926,0.034,0.001,1.604,0.352,1.873,0.048,0.352,P>0.05)。377例动脉导向组患者和578例静脉对照组患者分别发生乳糜漏32例和14例,两组比较,差异有统计学意义(x2=18.312,P<0.05)。所有乳糜漏患者通过保守治疗好转,无二次手术病例。其他发生并发症的患者经抗感染、补液、再次手术治疗后均好转。955例患者中,4例患者术后救治无效死亡。(3)术后病理学检查情况:377例动脉导向组患者中,肿瘤病理学TNM分期Ⅰ期57例、Ⅱ期174例、Ⅲ期146例,肿瘤分化程度高分化 30例、中分化174例、低分化173例,标本肠管长度23 cm(21 cm,26 cm),阳性淋巴结检出数目0枚(0, 2枚),肿瘤最大直径5.0 cm(3.0 cm,6.0 cm),癌结节37例,脉管侵犯81例,神经侵犯 53例;578例静脉对照组患者上述指标分别为66、280、232例,33、303、242例,23 cm(21 cm,25 cm),0枚(0,2枚),5.0 cm(3.5 cm,6.0 cm),80例,108例,82例,两组患者上述指标比较,差异均无统计学意义 (Z=-1.020,-0.216,-0.243,-0.220,-0.814, x2=3.441,1.127,0.003,P>0.05)。377例动脉导向组和 578例静脉对照组患者淋巴结清扫数目分别为22.0枚(17.0枚,27.0枚)和18.0枚(15.0枚,22.0枚),两组比较,差异有统计学意义(Z=-7.800,P<0.05)。进一步分析202例经过淋巴结分组筛选的患者资料,166例动脉导向组患者淋巴结清扫数目和中央淋巴结清扫数目分别为25.0枚(20.0枚,31.3枚)和5.0枚(3.0枚,8.0枚);36例静脉对照组患者上述指标分别为21.5枚(18.0枚,28.8枚)和1.5枚(0,4.5枚),两组患者上述指标比较,差异均有统计学意义(Z=-1.995,-4.309,P<0.05)。(4)随访和生存情况:955例患者中,840例患者获得术后随访(动脉导向组346例,静脉对照组494例)。随访时间为1.0~73.2个月,中位随访时间为31.5个月。346例动脉导向组患者和494例静脉对照组患者5年总体生存率分别为91.8%和84.9%,两组比较,差异有统计学意义(x2=4.384,P<0.05)。346例动脉导向组患者和494例静脉对照组患者5年无瘤生存率分别为84.4%和78.2% ,两组比较,差异无统计学意义(x2=2.158,P>0.05)。
    结论:与以SMV为导向的右半结肠CME比较,以SMA为导向的右半结肠CME安全、可行,淋巴结检出数目更多,可以进行更大程度的淋巴结清扫。

     

    Abstract: Objective:To investigate the application value of superior mesenteric artery (SMA)oriented complete mesocolic excision (CME) in the treatment of right colon cancer.
    Methods:The retrospective cohort study was conducted. The clinicopathological data of 955 patients with right colon cancer who were admitted to the First Affiliated Hospital of Nanjing Medical University from January 2013 to June 2018 were collected. There were 514 males and 441 females, aged from 18 to 96 years, with a median age of 65 years. Of the 955 patients, 377 undergoing SMA-oriented CME of right colon with the lymph node dissection along the left boundary of SMA were allocated into SMA-oriented group, and 578 undergoing superior mesenteric vein (SMV)oriented CME of right colon with the lymph node dissection along the left boundary of SMV were allocated into SMVoriented group. Observation indicators: (1) intraoperative and postoperative conditions; (2) postoperative complications; (3) postoperative pathological examinations; (4) follow-up and survival situations. Followup was performed by telephone interview and outpatient examination once every 3-6 months within 2 years after surgery and once a year after 2 years up to January 2019, using tumor recurrence and metastasis or death as the end point. Followup included physical examination and tumor marker test, including carcino embryonic antigen, CA199, chest and abdomen CT examination and enteroscopy. Measurement data with skewed distribution were described as M (P25, P75), and comparison between groups was done using the Mann-Whitney U test. Count data were described as absolute numbers or percentages, and comparison between groups was analyzed using the chi square test. Ordinal data were analyzed using the rank sum test. KaplanMeier method was used to calculate survival time and rate, and draw survival curve. Logrank test was used for survival analysis. Patients with loss to follow-up were involved in survival analysis as censored data.
    Results:(1) Intraoperative and postoperative conditions: the operation time, volume of intraoperative blood loss, duration of postoperative hospital stay were 100 minutes (90 minutes,110 minutes), 50.0 mL (50.0 mL, 70.0 mL), 8 days (8 days,10 days) in the SMA-oriented group, and 110 minutes (90 minutes, 135 minutes), 50.0 mL (50.0 mL,122.5 mL),10 days (8 days,12 days) in the SMVoriented group, showing significant differences between the two groups (Z=-5.400,-5.799,-7.461, P<0.05). After the exclusion of 47 patients unsuitable for defecation analysis because of postoperative complications, 365 in the SMA-oriented group and 543 in the SMVoriented group were analyzed. The time to first defecation, the maximum number and the median number of daily defecation postoperatively were 5 days (3 days, 5 days), 2.0 (1.0, 2.5), 1.0 (1.0, 1.0) in the SMA-oriented group, which showed no significant difference from 4 days (3 days, 5 days), 2.0 (1.0, 3.0), 1.0 (1.0, 1.0) in the SMVoriented group (Z=-1.622,-1.541, -1.024, P>0.05). (2) Postoperative complications: cases with postoperative complications, cases with incisional liquefaction or infection, cases with anastomostic leakage, cases with delayed gastric emptying, cases with intraabdominal bleeding, cases with complete or incomplete ileus, cases with anastomostic bleeding, cases with intraabdominal infection, cases with disruption of wound, the number of death were 55, 10, 3, 3, 2, 2, 1, 1, 1, 1 in the SMA-oriented group, which showed no significant difference from 83, 30, 13, 4, 3, 8, 3, 6, 2, 3 in the SMVoriented group, respectively (x2=0.045, 3.662, 2.926, 0.034, 0.001, 1.604, 0.352, 1.873, 0.048, 0.352, P>0.05). There were 32 of 377 patients in the SMA-oriented group and 14 of 578 in the SMVoriented group with chylous leakage, showing a significant difference between the two groups (x2=18.312, P<0.05). Patients with chylous leakage were improved after conservative treatment, without reoperation. Patients with other complications were improved after antiinfection, fluid infusion, and reoperation. Four of 955 patients died after surgery. (3) Postoperative pathological examinations: patients with stage Ⅰ, stage Ⅱ, and stage Ⅲ (pathological TNM staging), patients with highdifferentiation, middifferentiation, and lowdifferentiation (tumor differentiation degree), length of intestine specimen, number of positive lymph nodes, maximum tumor diameter, patients with cancer nodules, patients with vascular invasion, patients with perineural invasion were 57, 174, 146, 30, 174, 173, 23 cm (21 cm, 26 cm), 0 (0, 2), 5.0 cm (3.0 cm, 6.0 cm), 37, 81, 53 in the SMA-oriented group, which showed no difference from 66, 280, 232, 33, 303, 242, 23 cm (21 cm, 25 cm), 0 (0,2), 5.0 cm (3.5 cm, 6.0 cm), 80, 108, 82 in the SMVoriented group (Z=-1.020,-0.216,-0.243, -0.220,-0.814, x2=3.441, 1.127, 0.003, P>0.05). The number of harvested lymph nodes was 22.0 (17.0, 27.0) and 18.0 (15.0, 22.0) in the SMA-oriented group and SMVoriented group, respectively, with a significant difference between the two groups (Z=-7.800, P<0.05). There were 202 patients extracted for further analysis. The number of harvested lymph nodes and harvested central lymph nodes was 25.0 (20.0, 31.3), 5.0 (3.0, 8.0) of 166 patients in the SMA-oriented group, and 21.5 (18.0, 28.8), 1.5 (0, 4.5) of 36 patients in the SMVoriented group, respectively, showing significant differences between the two groups (Z=-1.995, -4.309, P<0.05). (4) Followup and survival situations: 840 of 955 patients including 346 in the SMA-oriented group and 494 in the SMVoriented group were followed up for 1.0-73.2 months, with a median time of 31.5 months. SMA-oriented group had a higher 5year overall survival rate than SMVoriented group (91.8% vs. 84.9%, x2=4.384, P<0.05), but had no significant difference in the 5year tumorfree survival rate compared with the SMVoriented group (84.4% vs. 78.2%, x2=2.158, P>0.05).
    Conclusion:Compared with SMVoriented CME of right colon, SMA-oriented CME of right colon is safe and feasible, with larger number of harvested lymph nodes, which can achieve complete lymph node dissection.

     

/

返回文章
返回